121 related articles for article (PubMed ID: 22466257)
1. Genome-wide identification of structural variants in genes encoding drug targets: possible implications for individualized drug therapy.
Rasmussen HB; Dahmcke CM
Pharmacogenet Genomics; 2012 Jul; 22(7):471-83. PubMed ID: 22466257
[TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetic mechanisms underlying unanticipated drug responses.
Carlquist JF; Anderson JL
Discov Med; 2011 May; 11(60):469-78. PubMed ID: 21616045
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics: technologies to detect copy number variations.
Dhawan D; Padh H
Curr Opin Mol Ther; 2009 Dec; 11(6):670-80. PubMed ID: 20072944
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacogenomics: the quest for individualized therapy].
López-López M; Guerrero-Camacho JL; Familiar-López IM; Jung-Cook H; Corona-Vázquez T; Alonso-Vilatela ME
Rev Neurol; 2004 Dec 1-15; 39(11):1063-71. PubMed ID: 15597270
[TBL] [Abstract][Full Text] [Related]
6. Analysis of adverse drug reactions using drug and drug target interactions and graph-based methods.
Lin SF; Xiao KT; Huang YT; Chiu CC; Soo VW
Artif Intell Med; 2010; 48(2-3):161-6. PubMed ID: 19962282
[TBL] [Abstract][Full Text] [Related]
7. Genetic factors in drug metabolism.
Belle DJ; Singh H
Am Fam Physician; 2008 Jun; 77(11):1553-60. PubMed ID: 18581835
[TBL] [Abstract][Full Text] [Related]
8. Structural variation and its effect on expression.
Harewood L; Chaignat E; Reymond A
Methods Mol Biol; 2012; 838():173-86. PubMed ID: 22228012
[TBL] [Abstract][Full Text] [Related]
9. Trends in exploration of therapeutic targets.
Zheng CJ; Han LY; Yap CW; Xie B; Chen YZ
Drug News Perspect; 2005 Mar; 18(2):109-27. PubMed ID: 15883620
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics in biological perspective.
Kalow W
Pharmacol Rev; 1997 Dec; 49(4):369-79. PubMed ID: 9443163
[TBL] [Abstract][Full Text] [Related]
11. Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease).
Roses AD; Saunders AM; Huang Y; Strum J; Weisgraber KH; Mahley RW
Pharmacogenomics J; 2007 Feb; 7(1):10-28. PubMed ID: 16770341
[TBL] [Abstract][Full Text] [Related]
12. Drug-target network.
Yildirim MA; Goh KI; Cusick ME; Barabási AL; Vidal M
Nat Biotechnol; 2007 Oct; 25(10):1119-26. PubMed ID: 17921997
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenomics in the assessment of therapeutic risks versus benefits: inside the United States Food and Drug Administration.
Zineh I; Pacanowski MA
Pharmacotherapy; 2011 Aug; 31(8):729-35. PubMed ID: 21923598
[TBL] [Abstract][Full Text] [Related]
14. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
Zhou SF; Liu JP; Chowbay B
Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics and the concept of individualized medicine.
Shastry BS
Pharmacogenomics J; 2006; 6(1):16-21. PubMed ID: 16302022
[TBL] [Abstract][Full Text] [Related]
16. Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.
Cacabelos R
Methods Find Exp Clin Pharmacol; 2007 Jul; 29 Suppl A():1-91. PubMed ID: 17957277
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450 polymorphism--molecular, metabolic, and pharmacogenetic aspects. III. Influence of CYP genetic polymorphism on population differentiation of drug metabolism phenotype.
Tomaszewski P; Kubiak-Tomaszewska G; Łukaszkiewicz J; Pachecka J
Acta Pol Pharm; 2008; 65(3):319-29. PubMed ID: 18646551
[TBL] [Abstract][Full Text] [Related]
18. Prediction of potential drug targets based on simple sequence properties.
Li Q; Lai L
BMC Bioinformatics; 2007 Sep; 8():353. PubMed ID: 17883836
[TBL] [Abstract][Full Text] [Related]
19. [Tailor-made drug therapy].
Ozawa S; Sawada J
Nihon Rinsho; 2001 Jan; 59(1):195-201. PubMed ID: 11197856
[TBL] [Abstract][Full Text] [Related]
20. Medicines for children licensed by the European Agency for the Evaluation of Medicinal Products.
Ceci A; Felisi M; Catapano M; Baiardi P; Cipollina L; Ravera S; Bagnulo S; Reggio S; Rondini G
Eur J Clin Pharmacol; 2002 Nov; 58(8):495-500. PubMed ID: 12451425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
